Modalis Therapeutics Corporation (TYO:4883)
Japan · Delayed Price · Currency is JPY 28.00
0.00 (0.00%)
Oct 26, 2026, 3:30 PM JST
Modalis Therapeutics Market Cap
Modalis Therapeutics has a market cap or net worth of 2.98 billion as of October 26, 2026. It is the 37,288th most valuable company in the world and the 3,471st biggest in Japan. Its market cap has decreased by 50.32% in one year.
Market Cap
2.98B
Enterprise Value
235.99M
Revenue
n/a
Global Rank
Country Rank
#3,471 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 3, 2020, Modalis Therapeutics's market cap has decreased from 60.66B to 2.98B, a decrease of -95.09%. That is a compound annual growth rate of -38.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 2.98B | -36.57% |
| Dec 30, 2025 | 4.70B | -33.61% |
| Dec 30, 2024 | 7.08B | 80.79% |
| Dec 29, 2023 | 3.92B | -59.92% |
| Dec 30, 2022 | 9.77B | -44.97% |
| Dec 30, 2021 | 17.75B | -71.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kringle Pharma | 5.12B |
| PRISM BioLab Co.,LTD | 4.88B |
| Kohjin Bio | 3.92B |
| Chordia Therapeutics | 3.86B |
| Noile-Immune Biotech | 3.82B |
| Ribomic | 3.73B |
| D. Western Therapeutics Institute | 3.68B |
| Transgenic Group | 3.45B |